v3.25.1
Common Stock Options
6 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Common Stock Options

Note 11 – Common Stock Options

 

Stock Incentive Plan

 

On June 21, 2016, we amended and restated our 2012 Stock Incentive Plan (the “2012 Plan”), which was originally adopted on March 5, 2012, and terminated on March 5, 2022. As amended, the 2012 Plan provided for the issuance of up to 11,500,000 shares of common stock pursuant to the grant of options or other awards, including stock grants, to employees, officers or directors of, and consultants to, the Company and its subsidiaries. Options granted under the 2012 Plan may either be intended to qualify as incentive stock options under the Internal Revenue Code of 1986, or may be non-qualified options, and are exercisable over periods not exceeding ten years from date of grant. 

 

Common Stock Option Issuances

 

There were no issuances of common stock options during the six months ended March 31, 2025.

 

  

Amortization of Stock-Based Compensation

 

A total of $0 and $1,153 of stock-based compensation expense was recognized during the six months ended March 31, 2025 and 2024, respectively, as a result of the vesting of common stock options issued in prior periods. As of March 31, 2025 no additional amounts of unamortized expense remains to be amortized over the vesting period.

 

The following is a summary of information about the stock options outstanding at March 31, 2025.

 

Shares Underlying Options Outstanding   Shares Underlying
Options Exercisable
 
        Weighted            
    Shares   Average  Weighted   Shares   Weighted 
Range of   Underlying   Remaining  Average   Underlying   Average 
Exercise   Options   Contractual  Exercise   Options   Exercise 
Prices   Outstanding   Life  Price   Exercisable   Price 
$.0056-0.13    8,120,000   3.62 years  $0.052    8,120,000   $0.052 

 

The following is a summary of activity of outstanding common stock options:

 

       Weighted 
       Average 
   Number   Exercise 
   of Shares   Price 
Balance, September 30, 2024   8,120,000   $0.052 
Options issued   -    - 
Options forfeited   -    - 
           
Balance, March 31, 2025   8,120,000   $0.052 
           
Exercisable, March 31, 2025   8,120,000   $0.052 

 

As of March 31, 2025, these options in the aggregate had $40,690 of intrinsic value for the outstanding and exercisable options, based on the per share market price of $0.025 of the Company’s common stock as of such date.